Medical Devices Seed Investors & VC Firms
1305 firms in this list, with a median first check of $365K. 278 of them lead rounds. Generated from verified public data and updated continuously.
JDRF T1D Fund
BostonSeed–Series A
30 people
IT-Farm Corporation
TokyoSeed–Series A
7 people
Lumira Ventures
TorontoSeed–Growth$1M – $10M
17 people
Signal Peak Ventures
Salt Lake CityPre-Seed–Series B$250K – $5M
15 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
26 people
Next Level Ventures
Des MoinesSeed–Growth$500K – $5M
15 people
EMV Capital
LondonSeed–Series A
21 people
YuanBio Venture Capital
SuzhouSeed–Growth
18 people
EcoR1 Capital
San FranciscoSeed–Late Stage
17 people
mHUB
ChicagoPre-Seed–Seed$200K
35 people
Movac
AucklandSeed–Growth$600K – $3M
26 people
Blackbird Bioventures
BaltimorePre-Seed–Seed
39 people
Emles Venture Partners
New YorkPre-Seed–Seed
14 people
TEL Venture Capital, Inc.
FremontPre-Seed–Growth
26 people
Peregrine Ventures
Or YehudaSeed–Late Stage$500K – $3M
14 people
venBio Partners
San FranciscoSeed–Series C
10 people
MIG Capital AG
MunichSeed–Series A$1.1M – $10.8M
25 people
Shanghai Healthcare Capital
ShanghaiSeed–Series B
45 people
Verge HealthTech Fund
SingaporePre-Seed–Series A$500K – $1.5M
24 people
SPRINGROCK VENTURES
SeattleSeed–Series A$2M – $5M
14 people
Ananda Impact Ventures
MunichPre-Seed–Series B$540K – $3.2M
15 people
Sv Tech Ventures, Inc.
Palo AltoSeed–Series A
9 people
Fortune Venture Capital
ShenzhenSeed–Series C
11 people
Borski Fund
AmsterdamSeed–Series A
27 people
Related lists
Seed Investors & VC Firms (11955)Seed Investors & VC Firms in North America (6148)Seed Investors & VC Firms in United States (5500)AI & Machine Learning Seed Investors & VC Firms (3743)Fintech Seed Investors & VC Firms (3447)SaaS Seed Investors & VC Firms (3339)Seed Investors & VC Firms in Europe (3336)Enterprise Software Seed Investors & VC Firms (3288)Healthtech Seed Investors & VC Firms (3233)Seed Investors & VC Firms in Global (3168)
Data sourced from public filings and firms' own websites — see our methodology.































































































